Innate Pharma Releases Shareholder Information as of December 18, 2025
ByAinvest
Monday, Dec 22, 2025 1:03 am ET1min read
IPHA--
As of December 18, 2025, Innate Pharma has a total of 92,197,823 ordinary shares and 6,324 Preferred Shares 2016 and 7,581 Preferred Shares 2017. The total number of theoretical voting rights is 92,962,943, while the total number of exercisable voting rights is 92,944,368. The number of shares and voting rights are disclosed pursuant to the French "Code de Commerce" and the AMF General Regulation.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet